LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Neratinib
0.00043333
 65.61 770.25 9401 9736 0.9656 0.9810
MN20160304_L02
H08
MCF 10A-H2B-mCherry Neratinib
0.00043333
 67.83 770.25 8815 10078 0.8746 0.9291
MN20160304_L02
G05
MCF 10A-H2B-mCherry Neratinib
0.00043333
 67.83 770.25 9666 10078 0.9591 0.9776
MN20160304_L02
H08
MCF 10A-H2B-mCherry Neratinib
0.00043333
 70.05 770.25 9117 10413 0.8755 0.9305
MN20160304_L02
G05
MCF 10A-H2B-mCherry Neratinib
0.00043333
 70.05 770.25 10053 10413 0.9654 0.9813
MN20160304_L02
H08
MCF 10A-H2B-mCherry Neratinib
0.00043333
 72.27 770.25 9252 10730 0.8622 0.9235
MN20160304_L02
G05
MCF 10A-H2B-mCherry Neratinib
0.00043333
 72.27 770.25 10286 10730 0.9585 0.9778
MN20160304_L02
H08
MCF 10A-H2B-mCherry Neratinib
0.00043333
 74.50 770.25 9450 10991 0.8598 0.9227
MN20160304_L02
G05
MCF 10A-H2B-mCherry Neratinib
0.00043333
 74.50 770.25 10466 10991 0.9522 0.9746
MN20160304_L02
H08
MCF 10A-H2B-mCherry Neratinib
0.00043333
 76.75 770.25 9648 11262 0.8566 0.9216
MN20160304_L02
G05
MCF 10A-H2B-mCherry Neratinib
0.00043333
 76.75 770.25 10629 11262 0.9437 0.9703
MN20160304_L02
H08
MCF 10A-H2B-mCherry Neratinib
0.00043333
 78.98 770.25 9746 11518 0.8461 0.9162
MN20160304_L02
G05
MCF 10A-H2B-mCherry Neratinib
0.00043333
 78.98 770.25 10830 11518 0.9403 0.9687
MN20160304_L02
H08
MCF 10A-H2B-mCherry Neratinib
0.00043333
 81.20 770.25 9901 11766 0.8415 0.9141
MN20160304_L02
G05
MCF 10A-H2B-mCherry Neratinib
0.00043333
 81.20 770.25 11161 11766 0.9486 0.9733
MN20160304_L02
H08
MCF 10A-H2B-mCherry Neratinib
0.00043333
 83.42 770.25 9988 12031 0.8301 0.9083
MN20160304_L02
G05
MCF 10A-H2B-mCherry Neratinib
0.00043333
 83.42 770.25 11357 12031 0.9439 0.9711
MN20160304_L02
H08
MCF 10A-H2B-mCherry Neratinib
0.00043333
 85.64 770.25 10121 12287 0.8237 0.9052
MN20160304_L02
G05
MCF 10A-H2B-mCherry Neratinib
0.00043333
 85.64 770.25 11517 12287 0.9373 0.9679
MN20160304_L02
H08
MCF 10A-H2B-mCherry Neratinib
0.00043333
 87.86 770.25 10207 12543 0.8137 0.9002
MN20160304_L02
G05
MCF 10A-H2B-mCherry Neratinib
0.00043333
 87.86 770.25 11782 12543 0.9393 0.9691
MN20160304_L02
H08
MCF 10A-H2B-mCherry Neratinib
0.0013333
 3.21 770.25 869 904 0.9606 0.6820
MN20160304_L02
E03
MCF 10A-H2B-mCherry Neratinib
0.0013333
 3.21 770.25 869 904 0.9606 0.6820
MN20160304_L02
F06
MCF 10A-H2B-mCherry Neratinib
0.0013333
 5.44 770.25 954 1012 0.9420 0.7191
MN20160304_L02
E03
MCF 10A-H2B-mCherry Neratinib
0.0013333
 5.44 770.25 1014 1012 1.0012 1.0063
MN20160304_L02
F06